InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Farzan Nima. Officer active across 2 companies, notably Kinnate Biopharma Inc.. In total, 2 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €24k. Activity tracked since 4 June 2026. The latest transaction was disclosed on 4 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations